Shefali AGARWAL, MD

Before joining Onxeo, Dr. Shefali Agarwal was Chief Medical Officer at Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies […]

Julien MIARA

Julien Miara is a Principal at Invus. He joined in 2010 as an analyst in the Public Equity group, covering […]

Bryan GIRAUDO

Bryan Giraudo is both the Chief Operating Officer & Chief Financial Officer of Gossamer Bio, a U.S. listed biopharmaceutical company […]

Nicolas TREBOUTA

Nicolas Trebouta is a Doctor of Medicine. Co-founder of Chevrillon and Associates in 2000, Nicolas Trebouta has lead several buyouts […]

Danièle GUYOT-CAPARROS

Danièle Guyot-Caparros is a chartered accountant. Danièle Guyot-Caparros is graduated from the Ecole Supérieure de Commerce of Nancy in finance […]

Jacques MALLET

Jacques Mallet, MD, served as SVP – Head of Portfolio Analytics/Corporate Strategy and Member of the Executive Leadership Team of […]

Robert L. COLEMAN

Robert L. Coleman, MD, is the Chief Scientific Officer of US Oncology Research, one of the U.S. largest networks dedicated […]